The acceptance of the microbiome diet as a means of achieving gut health among consumers could pave a path for a shift in attitude towards GM food, according to Michael Miille CEO at Joyn Bio.
Proponents of GM food contend that genetic engineering can help us find sustainable ways to feed people. One proponent is the US start-up Joyn Bio, a joint ag-tech venture between synthetic biology company Ginkgo Bioworks and pharma giant Bayer, which was formed in 2017 with a $100 million Series A round coming from its two parent companies.
Joyn Bio is attempting to engineer microbes that can provide plants with biological nitrogen fertilizer, thus decreasing the environmental impact of agriculture.
By engineering microbes it can eliminate the need for synthetic fertilizers, which have boosted crop yields over the past century but in the process have harmed soil health and caused environmental ills. Runoff from excess nitrogen fertilizer into rivers and oceans has created a dead zone of toxic algae in the Gulf of Mexico the size of New Jersey, for example.
Joyn Bio is headquarted in Boston. Its testing facility in California focuses on the genetic modification of the colonies of bacteria that make up crops microbiomes. It can then engineer those microbes to produce specific proteins as possible alternative to chemical fertilizers and other chemicals.
Any product is unlikely to be ready for market before 2020. Neither will any product be offered in Europe, where regulations do not currently permit engineered microbial products as produced by Joyn Bio (its current focus is on offering its solution to growers in the US, Brazil and India).
It believes nevertheless that it offers a potential global solution to the challenges facing the food industry. Its goal is to engineer microbes to reduce the amount of industrial nitrogen fertilizer needed to grow crops like corn, wheat, or rice, to dramatically decrease the water pollution, fossil fuel used and greenhouse gases produced by agriculture today.
"What we were really launched around was nitrogen fixation and recognising the environmental impact both in production and in application of the synthetic nitrogen fertilisers, which is not sustainable, then at the same time trying to come up with a solution,explained Miille.
Growers, he believes, are in desperate need of innovation and additional solutions given all the things they are confronting.Joyn Bio claims it can help farmers increase yield by promoting stronger plants and better nutrient uptake, ultimately contributing to the transformation of agriculture towards a more sustainable future.
How exactly does it all work? Our product would be a microbe that associates with the plant and is delivered as a seed treatment, said Miille.
Image the microbe as a trillion little FedEx trucks running all over the plant delivering cargo, he says. That cargo then takes nitrogen from the air, converts it into the nitrogen that the plant needs, and then gives it to the plant.
Its very similar to what happens in a soy bean plant naturally via evolution, but the soy and wheat plants never did that.
All this can allow a grower to reduce their fertilizer input by 30-40%, thus saving the grower money and allowing them to benefit from an environmental standpoint.
The process could potentially be used to make food more nutritious too. "You could use the microbes to signal the plant to potentially produce more of its nutritious part - there are number of nutrition enhancements that you can engineer. It's not our initial focus because it's a little more challenging but [improved nutrition] is certainly something people are looking at across the whole food spectrum today.
GM foods have something of a toxic legacy with European consumers, however, of which Miille is well aware. His solution to this challenge is simply to be straight with people. The problems of the past came about because companies such as Monsanto failed to be, he said. "Were trying to learn from that. I think its really critical to be transparent with consumers. Well want them to know we have these engineered microbes and here's what they did.
If crops produced via engineered microbes are used to grow something viable then people will accept it, he believes. Take the papaya industry in Hawaii, he noted, which was saved by GMO technology. "The same thing is going to happen with the US chestnut industry. There are going to be more examples of a pest or diseases that will threaten to wipe something out and the solution is biotechnology. And when you can save something when its that dramatic a benefit and you can communicate that to consumers, they get it.
He continued: For those of us on the science, technology and innovation side, the important thing is to understand how critical it is to engage with consumers and be transparent with them. The other side of the equation is to be able to articulate the benefit. If the benefit is that you either have strawberries or you don't, people will get that.
"Another thing in our favour is that peoples opinions and concerns about chemicals are probably at an all-time high.
The growth in popularity of the microbiome diet among consumers is another potential factor in Joyn Bios favour. If consumers now accept that the microbes in our gut play a critical role in overall health, whats not to stop them accepting the importance microbes could potentially have in agriculture?
More people than ever are taking probiotics because it improves gut health, said Miille. The next step is to say to consumers that microbes are part of the solution and all we've really done is taken this microbe and selectively optimised it for its particular purpose. These kind of discussions, he said, will get people to accept that microbes are going to be an integral part of agriculture over the next 20-30 years.
Originally posted here:
Microbes 'set to be an integral part of agriculture over the next 20-30 years': Joyn Bio - FoodNavigator.com
- genetic engineering summary | Britannica - September 13th, 2024
- The great gene editing debate: can it be safe and ethical? - BBC.com - September 13th, 2024
- Anti-biotechnology campaigners embrace classic crops, are suspicious of hybrid varieties and claim genetic modification violates nature. Heres a... - September 13th, 2024
- Will IL-11 Control Extend Human Life One Day? Early Results are Tantalizing - Securities.io - September 13th, 2024
- Viewpoint: As New Zealand edges toward relaxing its ban on gene edited foods, experts weigh in - Genetic Literacy Project - September 13th, 2024
- Farmers in Brazil and Argentina ramp up growing of genetically-modified drought tolerant wheat that can grow in subtropical regions - Genetic Literacy... - September 13th, 2024
- Scientist explains why we'll never have a real Jurassic Park - and people are crestfallen - indy100 - September 13th, 2024
- Genetic engineering techniques - Wikipedia - January 9th, 2024
- 20.3: Genetic Engineering - Biology LibreTexts - January 9th, 2024
- Genetic engineering - DNA Modification, Cloning, Gene Splicing - December 13th, 2023
- Global Gene Editing Market Poised for Significant Growth, Projected to Reach $14.28 Billion by 2027 - EIN News - December 13th, 2023
- Principles of Genetic Engineering - PMC - National Center for ... - May 17th, 2023
- Quitting: A Life Strategy: The Myth of Perseveranceand How the New Science of Giving Up Can Set You Free - Next Big Idea Club Magazine - May 17th, 2023
- 18 Human Genetic Engineering - Clemson University - March 29th, 2023
- Pros and Cons of Genetic Engineering - Benefits and Risks - March 29th, 2023
- How artificial skin is made and its uses, from treating burns to skin cancer - South China Morning Post - March 29th, 2023
- Genetic Engineering - Meaning, Applications, Advantages and Challenges ... - March 13th, 2023
- Revolutionary Specialty Enzymes Transform Industries, Projected to Reach $2.2 Billion by 2031 - Billion-Dollar - EIN News - March 5th, 2023
- Explained: What is genome editing technology and how is it different from GM technology? - The Indian Express - April 2nd, 2022
- Scribe Therapeutics to Participate in Upcoming Goldman Sachs The New Guard: Privates Leading the Disruption in Healthcare Investor Conference - Yahoo... - April 2nd, 2022
- San Antonio Zoo In Discussions on Woolly Mammoth Project - iHeart - April 2nd, 2022
- Xenotransplantation trials will require adjusting expectations, experts say - STAT - April 2nd, 2022
- 5 Interesting Startup Deals You May Have Missed In March: Restoring The Woolly Mammoth, Faux Seafood And Lots Of Bees - Crunchbase News - April 2nd, 2022
- Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for ... - KULR-TV - April 2nd, 2022
- The Bay Area food tech industry is creating more than vegan burgers. Heres whats next - San Francisco Chronicle - April 2nd, 2022
- Student Startup Teams to Compete For $110000 Cash Prize Pool in U of A's Heartland Challenge - University of Arkansas Newswire - April 2nd, 2022
- Should we test for differences in allergen content between varieties of crops and animal species? - Open Access Government - April 2nd, 2022
- Genetic Engineering - Courses, Subjects, Eligibility ... - December 22nd, 2021
- Scientists Used CRISPR Gene Editing to Choose the Sex of Mouse Pups - Singularity Hub - December 22nd, 2021
- Report calls for broad public deliberation on releasing gene-edited species in the wild - EurekAlert - December 22nd, 2021
- RNA and DNA Extraction Kit Market Study | Know the Post-Pandemic Scenario of the Industry - BioSpace - December 22nd, 2021
- Opinion: Allow Golden Rice to save lives - pnas.org - December 22nd, 2021
- It's time for an alliance of democracies | TheHill - The Hill - December 22nd, 2021
- Aridis Pharmaceuticals Announces a Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19... - December 22nd, 2021
- 2021: when the link between the climate and biodiversity crises became clear - The Guardian - December 22nd, 2021
- Wuhan lab leak now the most likely cause of Covid pandemic and the truth WILL come out, experts tell MPs... - The US Sun - December 22nd, 2021
- Biotech ETFs That Outperformed Last Week - Yahoo Finance - December 22nd, 2021
- Human genetic enhancement - Wikipedia - October 5th, 2021
- Viewpoint: Part 1 Opposition stirred by anti-GMO advocacy group propaganda fading in the developing world, as more countries embrace crop... - October 5th, 2021
- Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx Genome Engineering Platform - WWNY - October 5th, 2021
- Kingdom Supercultures raises $25m to expand Non GMO suite of microbes to unlock new flavors, textures, and functionalities in food & beverage -... - October 5th, 2021
- Fact check: Genetically engineering your salad with the COVID-19 vaccines? We're not there yet. - USA TODAY - October 5th, 2021
- Making the Transition from an Academic to a Biobusiness Entrepreneur - Genetic Engineering & Biotechnology News - October 5th, 2021
- Is The New York Times Finally 'Learning To Love GMOS'? - American Council on Science and Health - October 5th, 2021
- Gene editing, joke theft and manifesting - The Week UK - October 5th, 2021
- Opinion: Saving lives through real social justice - Agri-Pulse - October 5th, 2021
- Science, business and the humanities: CP Snow's 'Two Cultures' sixty years on - TheArticle - October 5th, 2021
- Probiotic Yeast Engineered To Produce Beta-Carotene - Technology Networks - April 17th, 2021
- In the US, Imminent Release of Genetically Modified Mosquitoes To Fight Dengue - The Wire Science - April 17th, 2021
- CRISPRoff: A New Addition to the CRISPR Toolbox - Technology Networks - April 17th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 17th, 2021
- Grammar of the Genome: Reading the Influence of DNA on Disease - Baylor University - April 17th, 2021
- We cannot let China set the standards for 21st century technologies | TheHill - The Hill - April 17th, 2021
- First GMO Mosquitoes to Be Released in the Florida Keys - Singularity Hub - April 17th, 2021
- Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations - BioSpace - April 17th, 2021
- AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses - OncoZine - April 17th, 2021
- StrideBio Announces a Multi-technology License and Master SRA with Duke University to Advance Next-generation Gene Therapies - BioSpace - April 17th, 2021
- ThermoGenesis : The History of Cell and Gene Therapy - marketscreener.com - April 17th, 2021
- EU's refusal to permit GMO crops led to millions of tonnes of additional CO2, scientists reveal - Alliance for Science - Alliance for Science - February 14th, 2021
- New species of fly named after Singanallur Tank - The Hindu - February 14th, 2021
- Son of Monarchs Pays Homage to the Beauty of Migration - Sierra Magazine - February 14th, 2021
- Podcast: TIME's 2020 Kid of the Year, Gitanjali Rao - All Together - Society of Women Engineers - February 14th, 2021
- Geoengineering: What could possibly go wrong? Elizabeth Kolbert's take, in her new book - Bulletin of the Atomic Scientists - February 14th, 2021
- An Introduction to PCR - Technology Networks - February 14th, 2021
- Science Talk - Evolution, cancer and coronavirus how biology's 'Theory of Everything' is key to fighting cancer and global pandemics - The Institute... - February 14th, 2021
- 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with... - February 14th, 2021
- Aleph Farms and The Technion Reveal World's First Cultivated Ribeye Steak - PRNewswire - February 9th, 2021
- Researchers create rice that captures more CO2 with 30 percent more yield - FoodIngredientsFirst - February 9th, 2021
- Interview: Elizabeth Kolbert on why well never stop messing with nature - Grist - February 9th, 2021
- Is Biotechnology the Answer to a More Sustainable Beauty Industry? - Fashionista - February 9th, 2021
- New Jersey arts and entertainment news, features, and event previews. - New Jersey Stage - February 9th, 2021
- CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft... - February 9th, 2021
- Taysha Gene Therapies Announces Collaborations to Advance Next-Generation Mini-Gene Payloads for AAV Gene Therapies for the Treatment of Genetic... - February 9th, 2021
- A new tool to investigate bacteria behind hospital infections - MIT News - February 9th, 2021
- Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts - GlobeNewswire - February 9th, 2021
- Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization - GlobeNewswire - February 9th, 2021
- Global Lab-On-A-Chip Market Industry Perspective, Comprehensive Analysis, and Forecast 2027||Players-Perkin Elmer Corporation, IDEX, Thermo Fisher... - February 9th, 2021
- Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium - PharmiWeb.com - February 9th, 2021
- Global Bacterial and Plasmid Vectors Market Report 2020: Market is Expected to Recover and Reach $0520 Million in 2023 at a CAGR of 15.48% - Forecast... - January 12th, 2021
- mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry - TIME - January 12th, 2021